PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23360591 ↗2013Reported benefit

Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion.

MouseIschaemia-reperfusionIntestinal / mesentericC57BL/6Malen = n=5 per group for sham, vehicle and cRGDIntraperitoneal injection5 mg/kg body weight in 0.2 ml; a pilot dose of 10 mg/kg gav…1 h prior to ischaemia

Model: Intestinal ischaemia/reperfusion by superior mesenteric artery occlusion for 45 min followed by reperfusion, with tissues collected 4 h after reperfusion

cRGD reduced gut and lung injury scores by 70.6 and 60.0 per cent, cut gut and lung myeloperoxidase by 77.8 and 54.2 per cent, lowered serum TNF-alpha and IL-6 by 71.0 and 67.9 per cent and reduced lung TUNEL-positive cells by 59.5 per cent.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.